한국어
English
日本語
中文(简体)
Actazone 15 mg Tablet (Pioglitazone Hydrochloride)
16.53mg
Tablet · Prescription medication
Daehan Pharmaceuticals Co., Ltd.
Pioglitazone hydrochloride is a blood glucose-lowering ingredient used in the treatment of type 2 diabetes.
MFDS ingredient code M092005
Pioglitazone hydrochloride is an oral hypoglycemic agent belonging to the thiazolidinedione class. It is mainly used to lower blood glucose levels in patients with type 2 diabetes. It helps control blood sugar by improving insulin resistance.
This ingredient increases sensitivity to insulin in the body, allowing glucose to be effectively absorbed into cells. This lowers blood glucose concentration in the bloodstream and alleviates the symptoms of diabetes.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other hypoglycemic agents, pioglitazone hydrochloride directly improves insulin resistance. Consequently, it does not stimulate insulin secretion, resulting in a relatively low risk of hypoglycemia.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.